Cardinal Health (CAH) Fundamental Analysis: Revenue, Earnings & Valuation

8.59 / 10

Outperform

Fundamental analysis shows robust quality: PB‑ROE, Asset‑MV, Cash‑MV and earnings growth rank in top quartiles, delivering 5‑6% monthly returns. Weak points are negative cash‑flow growth and low Revenue‑MV, which drag confidence slightly.

Analysis Checks(7/10)

Revenue-MV

Value2.74

Score0/3

Weight-11.55%

1M Return-6.19%

Net cash flow from operating activities per share (YoY growth rate %)

Value-34.95

Score0/3

Weight-5.76%

1M Return-2.82%

PB-ROE

Value-0.21

Score3/3

Weight18.99%

1M Return7.08%

Basic earnings per share (YoY growth rate %)

Value86.21

Score3/3

Weight16.09%

1M Return5.83%

Total profit (YoY growth rate %)

Value74.94

Score3/3

Weight14.20%

1M Return5.02%

Cash-UP

Value-0.56

Score1/3

Weight-0.64%

1M Return-0.29%

Diluted earnings per share (YoY growth rate %)

Value86.96

Score3/3

Weight16.66%

1M Return6.07%

Asset-MV

Value-0.55

Score3/3

Weight25.11%

1M Return8.41%

Net profit attributable to parent company shareholders (YoY growth rate %)

Value83.22

Score3/3

Weight11.48%

1M Return4.20%

Cash-MV

Value0.53

Score3/3

Weight15.43%

1M Return5.04%

Is CAH undervalued or overvalued?

CAH scores 8.59/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.00% ROE, 0.69% net margin, 29.87 P/E ratio, -18.39 P/B ratio, and 29.02% earnings growth, these metrics solidify its Outperform investment rating.